Market news

UnitedHealth Group Incorporated (NYSE:UNH) is getting a new head of its insurance division, with executive Robert Hunter disclosing on September 28 that he will take the role. Hunter announced it himself in a post on LinkedIn, and the firm has issued no comments on the reasoning. The division he is taking over is the one […]

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 15 years by 1.78% on an annualized basis producing an average annual return of 15.28%. Currently, UnitedHealth Group has a market capitalization of

UnitedHealth is showing signs of improvement after higher medical costs pressured earnings and margins, and Kevin Simpson is starting to buy the stock again.

CNBC’s final trades: Weiss picked UnitedHealth, Lebenthal chose AbbVie after FDA approval, and Terranova backed Okta amid raised price targets.

UnitedHealth raised 2026 adjusted diluted EPS guidance to $19.50–$20.00, reflecting strong margin discipline. Read why UNH stock is a Buy.

CNBC’s Final Trades: Rob Sechan picks Hewlett Packard, Kevin Simpson favors Natera, and Stephen Weiss recommends UnitedHealth.

Key Stats for UnitedHealth StockCurrent Price: $376. 59Target Price (Mid): ~$600Street Target: ~$482Potential Total Return: ~60%Annualized IRR: ~12% / yearWhat Happened?UnitedHealth Group (UNH) named Jodee Kozlak its first chief administrative officer on September 24, effective September 28, to oversee People, Real Estate, Procurement, and Corporate Security, two days after elevating Dan Kueter to chief commercial officer.

Three companies with nothing in common all sent dividend checks on the same September day, but only one of them handed shareholders a freshly raised rate. Which one broke from the pack, and what does each payout actually earn against the price investors paid?

UnitedHealth Group recently announced that Jodee Kozlak joined as chief administrative officer, a new role overseeing People, Real Estate, Procurement and Corporate Security to support enterprise modernization and alignment across the business. Kozlak’s background leading global expansion at Alibaba, human resources at Target, and board roles at C.H. Robinson Worldwide and KB Home suggests UnitedHealth is placing greater emphasis on organizational efficiency and large-scale transformation...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how UnitedHealth (NYSE:UNH) and the rest of the health insurance providers stocks fared in Q2.

Jodee Kozlak, a veteran of major multinational corporations, will join UnitedHealth this coming Monday to modernize and align the healthcare behemoth’s operations across its various businesses.

Key TakeawaysUnitedHealth’s commercial segment cost trend ran modestly above 11% in the first half of 2026, with roughly 100 basis points tied to arbitration abuse and provider coding intensity, the same billing dynamic a new Blue Cross Blue Shield Association study says cost insurers $942 million industry wide over two years. Management pushed commercial margin recovery past 2027, a full year later than planned, even as the consolidated medical care ratio improved to 86.

UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.

UnitedHealth Group has seen its share price deliver mixed results in recent years, with shorter term gains sitting alongside a longer multi year decline. That uneven share price path puts the spotlight on a simple question for investors who follow UnitedHealth Group stock: whether the current valuation is backed up by its earnings power. Over the past 3 years the stock has declined 21.4%, which puts more weight on whether the earnings profile justifies where the shares trade today. Recent...

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $372.8, denoting a -1.26% move from the preceding trading day.

UnitedHealth shows a margin turnaround and earnings growth outlook to 2028, with an undervalued P/E, a 2.46% yield, and buybacks. Learn more about UNH stock here.

Ahead of Luigi Mangione’s sentencing, the Last Week Tonight host looked into the corporate healthcare behemoth that is UnitedHealth Group

UnitedHealth Group’s recovery is gaining traction, with improving MCR, two 2026 EPS guidance raises, and stronger cash flow. Read more on UNH stock here.

Paul Harris of Toronto-based Harris Douglas Asset Management also likes Meta Platforms despite some of its risks

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

September 15, 2026--UnitedHealth Group will release its third quarter 2026 financial results on Tuesday, October 13, 2026, before the market opens.

Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Following a strong rebound from the first-quarter decline, the S&P 500 gained 15.2% as accelerating capital spending toward artificial intelligence infrastructure drove significant gains across technology hardware companies. Semiconductor and data-center-related businesses benefited from supply constraints […]

UnitedHealth (UNH) rated a buy: Q2 revenue/EPS beats, raised 2026 guidance, 6.9% FCF yield and EPS upgrades.

UnitedHealth Group Incorporated (NYSE:UNH) has sold an interest in some of its Optum Health operations in Florida to private-equity firm TPG, specifically involving its WellMed clinics that focus heavily on older patients. UnitedHealth’s CFO said the move is not about raising cash, but about bringing in a partner that can provide local operating expertise and […]

UnitedHealth Group Inc (NYSE:UNH) recently announced a total dividend of $2.32 per share, with the ex-dividend date set for 2026-09-14. This amount consists of $2.32 per share in cash dividends, payable on 2026-09-22. Investors should note that the ex-dividend date of 2026-09-14 means shareholders must own the stock before that date to qualify for the payment.

Optum Health hit a wall due to rising costs and restrictive Medicare Advantage payments.

In the latest trading session, UnitedHealth Group (UNH) closed at $379.09, marking a -2.37% move from the previous day.

Detailed price information for Unitedhealth Group (UNH-N) from The Globe and Mail including charting and trades.

Detailed price information for Unitedhealth Group (UNH-N) from The Globe and Mail including charting and trades.

UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.

UnitedHealth Group (NYSE:UNH) executives said the company’s turnaround remained on track, citing continued strength in Medicare Advantage, Medicaid performance that is tracking toward the favorable end of expectations, and operational improvements at Optum Health. Speaking at an investor conference

UnitedHealth Group Incorporated’s (NYSE:UNH) insurance unit is removing prior-authorization requirements from a broad range of healthcare services beginning October 1. The changes form part of UnitedHealthcare’s plan to eliminate such requirements for 30% of healthcare services by the end of 2026. The initiative could reduce administrative work for patients, providers, and the insurer itself while […]

The latest trading day saw UnitedHealth Group (UNH) settling at $393.06, representing a -1.94% change from its previous close.